BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Theocharis G, Rafailidis PI, Rodis D, Kontopidis I, Barbas SG, Falagas ME. Outpatient parenteral antibiotic therapy (OPAT) at home in Attica, Greece. Eur J Clin Microbiol Infect Dis. 2012;31:2957-2961. [PMID: 22653635 DOI: 10.1007/s10096-012-1647-1] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.7] [Reference Citation Analysis]
Number Citing Articles
1 Psaltikidis EM, Silva END, Bustorff-Silva JM, Moretti ML, Resende MR. Economic evaluation of outpatient parenteral antimicrobial therapy: a systematic review. Expert Rev Pharmacoecon Outcomes Res 2017;17:355-75. [PMID: 28776441 DOI: 10.1080/14737167.2017.1360767] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 3.5] [Reference Citation Analysis]
2 Sriskandarajah S, Hobbs J, Roughead E, Ryan M, Reynolds K. Safety and effectiveness of 'hospital in the home' and 'outpatient parenteral antimicrobial therapy' in different age groups: A systematic review of observational studies. Int J Clin Pract 2018;:e13216. [PMID: 29920884 DOI: 10.1111/ijcp.13216] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 4.7] [Reference Citation Analysis]
3 Mitchell ED, Czoski Murray C, Meads D, Minton J, Wright J, Twiddy M. Clinical and cost-effectiveness, safety and acceptability of community intravenous antibiotic service models: CIVAS systematic review. BMJ Open 2017;7:e013560. [PMID: 28428184 DOI: 10.1136/bmjopen-2016-013560] [Cited by in Crossref: 31] [Cited by in F6Publishing: 34] [Article Influence: 7.8] [Reference Citation Analysis]
4 Mackenzie M, Rae N, Nathwani D. Outcomes from global adult outpatient parenteral antimicrobial therapy programmes: A review of the last decade. International Journal of Antimicrobial Agents 2014;43:7-16. [DOI: 10.1016/j.ijantimicag.2013.09.006] [Cited by in Crossref: 53] [Cited by in F6Publishing: 48] [Article Influence: 7.6] [Reference Citation Analysis]
5 Boese CK, Lechler P, Frink M, Hackl M, Eysel P, Ries C. Cost-analysis of inpatient and outpatient parenteral antimicrobial therapy in orthopaedics: A systematic literature review. World J Clin Cases 2019; 7(14): 1825-1836 [PMID: 31417928 DOI: 10.12998/wjcc.v7.i14.1825] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
6 Mujal A, Sola J, Hernandez M, Villarino M, Baylina M, Tajan J, Oristrell J. Safety and effectiveness of outpatient parenteral antimicrobial therapy in older people. J Antimicrob Chemother 2016;71:1402-7. [DOI: 10.1093/jac/dkv478] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
7 Palms DL, Jacob JT. Close Patient Follow-up Among Patients Receiving Outpatient Parenteral Antimicrobial Therapy. Clin Infect Dis 2020;70:67-74. [PMID: 30810165 DOI: 10.1093/cid/ciz150] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 9.0] [Reference Citation Analysis]
8 Hernandez W, Price C, Knepper B, McLees M, Young H. Oral Parenteral Antimicrobial Therapy Administration in a Homeless Population. J Infus Nurs 2016;39:81-5. [PMID: 26934162 DOI: 10.1097/NAN.0000000000000165] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
9 Erba A, Beuret M, Daly ML, Khanna N, Osthoff M. OPAT in Switzerland: single-center experience of a model to treat complicated infections. Infection 2020;48:231-40. [PMID: 31828605 DOI: 10.1007/s15010-019-01381-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
10 Theocharis G, Barbas SG, Spiropoulos T, Stamouli PE, Perdikis DN, Falagas ME. Patient house calls in Attica and Thessaloniki, Greece (2005-2015): a model for out-of-hospital multispecialty emergency medicine. BMC Health Serv Res 2018;18:304. [PMID: 29703193 DOI: 10.1186/s12913-018-3111-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
11 Chung EK, Beeler CB, Muloma EW, Osterholzer D, Damer KM, Erdman SM. Development and implementation of a pharmacist-managed outpatient parenteral antimicrobial therapy program. Am J Health Syst Pharm 2016;73:e24-33. [PMID: 26683676 DOI: 10.2146/ajhp150201] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 2.4] [Reference Citation Analysis]
12 Versporten A, Bruyndonckx R, Adriaenssens N, Hens N, Monnet DL, Molenberghs G, Goossens H, Weist K, Coenen S; ESAC-Net study group. Consumption of tetracyclines, sulphonamides and trimethoprim, and other antibacterials in the community, European Union/European Economic Area, 1997-2017. J Antimicrob Chemother 2021;76:ii45-59. [PMID: 34312660 DOI: 10.1093/jac/dkab177] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
13 Laupland KB, Valiquette L. Outpatient parenteral antimicrobial therapy. Can J Infect Dis Med Microbiol 2013;24:9-11. [PMID: 24421785 DOI: 10.1155/2013/205910] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 2.1] [Reference Citation Analysis]
14 Minton J, Murray CC, Meads D, Hess S, Vargas-palacios A, Mitchell E, Wright J, Hulme C, Raynor DK, Gregson A, Stanley P, Mclintock K, Vincent R, Twiddy M. The Community IntraVenous Antibiotic Study (CIVAS): a mixed-methods evaluation of patient preferences for and cost-effectiveness of different service models for delivering outpatient parenteral antimicrobial therapy. Health Serv Deliv Res 2017;5:1-272. [DOI: 10.3310/hsdr05060] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]